Developer docs
API playgroundTry for free, no card

Search company profiles

MAASI Enterprises

Full company profile

uuid0005j4i

Namestring
MAASI Enterprises
Legal namestring
MAASI Enterprises
Websiteurl
maasi.eu
Company typeenum
Private
Founded yearint
2008
Descriptiontext

MAASI Enterprises is a London-headquartered, privately held advisory and consultancy joint venture formed by multiple European tech advisory and consultancy businesses, with a secondary operational entity in Italy and global delivery reach. The firm specialises in serving large multinational clients in the Pharmaceutical, Healthcare, and Biotechnology industries — what it characterises as "Highly Regulated Enterprises" — and operates with a headcount band of 11–50 employees under ISO 9001 Quality Management certification.

The company's offering is structured as a two-pillar service portfolio rather than a software product. Advisory Services covers M&A-related system and process migration, corporate standardisation, digital transformation, technology and process innovation, technology risk assessment and management, and industrial cybersecurity, delivered through sub-lines including Advisory and Integration, M&A and Special Programmes, and Business Services and Technical Analysis. Consultancy Services delivers 360° Consulting, SLA-defined Operations Outsourcing of technical IT and OT services, and medium- to long-term Interim Management placements of qualified technical professionals.

Commercially, MAASI runs a relationship-driven enterprise field-sales motion, pricing engagements on a bespoke, quote-based, multi-year basis to multinational life-science clients. Revenue is generated through professional services (advisory, consultancy, interim management) and managed services (outsourced IT/OT operations). No proprietary technology platform, API, AI/ML capability, or public pricing is disclosed, and the firm holds no recorded funding beyond an initial ~$118K round dated 2020-09-18; investor identities, cap-table structure, and customer logos are not publicly available.

Short descriptiontext

MAASI Enterprises is a London-based, privately held joint venture of European advisory firms providing technology and management advisory, IT/OT outsourcing, and interim management services to large multinational Pharmaceutical, Healthcare, and Biotechnology clients, with additional delivery capability from Italy.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersLondon, United Kingdom
HQ citystring
London
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
life science consulting, pharmaceutical advisory services, biotechnology consultancy, industrial cybersecurity consulting, IT/OT managed services
Industry1 code
PRIMARYBPAHADAI
Strategic Partnerships, Alliances & JVs Advisory
NAICS code1 code
  • Corporate, Subsidiary, and Regional Managing Offices551114
Product category
Life Science Consulting
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Advisory Services
TypeProfessional Services
Description

Project-based advisory engagements covering M&A-related system and process migration, corporate standardisation, digital transformation, technology and process innovation, technology risk assessment and management, and industrial cybersecurity. Delivered by senior advisors to large multinational clients in Pharmaceutical, Healthcare and Biotechnology industries.

maasi.enterprises
2Consultancy Services
TypeProfessional Services
Description

360° consulting engagements plus structured, SLA-defined outsourced technical IT and OT services and interim management placements. Engagements are tailor-made, structured and qualified to enterprise-grade standards.

maasi.enterprises
3Operations Outsourcing (Managed Services)
TypeManaged Services
Description

Tailor-made, structured, SLA-defined, enterprise-grade outsourced technical IT and OT services for life-science clients. Functions as a recurring managed-services revenue stream alongside project-based consulting.

maasi.enterprises
4Interim Management
TypeProfessional Services
Description

Medium- to long-term placement of qualified technical management professionals selected, trained and qualified by MAASI for client engagements.

maasi.enterprises
Cost components4 values
Personnel, Operations, Marketing or Sales, Technology or R&D
Pricing details1 tier
1Quote-based advisory, consultancy, managed outsourcing and interim management engagements
ModelOtherBilling cadenceMulti-year contract
Notes

No public price list disclosed; bespoke engagements tailored to large multinational life-science clients.

maasi.enterprises
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

MAASI Enterprises delivers qualified advisory and consultancy services to large multinational enterprises in highly regulated life-science industries (Pharmaceutical, Healthcare, Biotechnology). Its portfolio covers M&A-related system and process migration, corporate standardisation, digital transformation, technology risk assessment and management, industrial cybersecurity, SLA-defined IT/OT operations outsourcing, and interim technical management.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

MAASI Enterprises delivers a unified advisory-and-consultancy service portfolio for the life-science industry rather than a discrete software product. The portfolio is organised around two core service lines — Advisory Services and Consultancy Services — each broken into named sub-offerings. Advisory Services comprises Advisory and Integration, M&A and Special Programmes, and Business Services and Technical Analysis; Consultancy Services comprises 360° Consulting, Operations Outsourcing, and Interim Management. Together, these two pillars allow MAASI Enterprises to combine strategic advisory (e.g., M&A migration, digital transformation, technology risk, industrial cybersecurity) with hands-on delivery (SLA-defined IT/OT outsourcing and interim technical management) for multinational Pharmaceutical, Healthcare, and Biotechnology clients.

Product and service1 record
1Advisory Services
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Cognizant operates a global Life Sciences practice delivering IT services, digital transformation, regulatory compliance, and consulting to pharmaceutical and biotech clients — directly overlapping with MAASI's advisory and outsourcing offerings, but at vastly larger scale and with proprietary platforms.

TypeBroad incumbent
Description

TCS operates a dedicated Life Sciences & Healthcare practice delivering consulting, digital transformation, regulatory, and IT/OT services to global pharma and biotech clients — competing with MAASI for enterprise advisory and managed-services mandates.

TypeDirect peer
Description

SL Controls is a specialist life-science-focused automation and OT systems integrator serving pharmaceutical and medical-device manufacturers in Europe — a closer boutique-level peer to MAASI's IT/OT operations outsourcing and industrial cybersecurity offerings for regulated clients.

TypeBroad incumbent
Description

Capgemini's life-sciences-focused engineering and IT services arm delivers digital transformation, M&A integration, and managed services to pharmaceutical clients, overlapping substantially with MAASI's advisory and IT/OT outsourcing offerings across European pharma accounts.

5NNIT (now part of NNIT A/S)
TypeDirect peer
Description

NNIT is a Denmark-based IT services provider specialised in life sciences, offering infrastructure, application services, consulting, and managed services to pharmaceutical and biotech clients — a closer specialist peer to MAASI in scale, geography, and life-science-only focus.

TypeBroad incumbent
Description

PwC's Pharma & Life Sciences advisory practice covers strategy, M&A integration, technology risk, and digital transformation — directly comparable to MAASI's advisory portfolio for large multinational pharma, healthcare, and biotechnology clients.

TypeBroad incumbent
Description

Wipro runs a dedicated Life Sciences business unit providing consulting, IT services, digital operations, and outsourcing to pharmaceutical and medical-device clients — competing with MAASI on enterprise-grade IT/OT services for life-science multinationals.

TypeBroad incumbent
Description

Accenture's Life Sciences practice provides strategy, technology, consulting, and outsourcing to large multinational pharma, biotech, and medtech clients across M&A, digital transformation, cybersecurity, and operations — the same enterprise-grade service mix MAASI targets, but with global delivery scale MAASI cannot match.

TypeBroad incumbent
Description

Deloitte's Life Sciences practice delivers strategy, technology, risk advisory, and managed services to large pharma and biotech multinationals — competing directly with MAASI for advisory mandates around M&A, digital transformation, technology risk, and cybersecurity.

TypeBroad incumbent
Description

Infosys's Life Sciences practice offers consulting, digital transformation, and managed services to global pharmaceutical and biotech firms, overlapping with MAASI's advisory, consultancy, and operations outsourcing pillars at much larger scale.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

MAASI Enterprises

Life Science Consultingmaasi.eu

MAASI Enterprises is a London-based, privately held joint venture of European advisory firms providing technology and management advisory, IT/OT outsourcing, and interim management services to large multinational Pharmaceutical, Healthcare, and Biotechnology clients, with additional delivery capability from Italy.

What MAASI Enterprises does

MAASI Enterprises is a London-headquartered, privately held advisory and consultancy joint venture formed by multiple European tech advisory and consultancy businesses, with a secondary operational entity in Italy and global delivery reach. The firm specialises in serving large multinational clients in the Pharmaceutical, Healthcare, and Biotechnology industries — what it characterises as "Highly Regulated Enterprises" — and operates with a headcount band of 11–50 employees under ISO 9001 Quality Management certification.

The company's offering is structured as a two-pillar service portfolio rather than a software product. Advisory Services covers M&A-related system and process migration, corporate standardisation, digital transformation, technology and process innovation, technology risk assessment and management, and industrial cybersecurity, delivered through sub-lines including Advisory and Integration, M&A and Special Programmes, and Business Services and Technical Analysis. Consultancy Services delivers 360° Consulting, SLA-defined Operations Outsourcing of technical IT and OT services, and medium- to long-term Interim Management placements of qualified technical professionals.

Commercially, MAASI runs a relationship-driven enterprise field-sales motion, pricing engagements on a bespoke, quote-based, multi-year basis to multinational life-science clients. Revenue is generated through professional services (advisory, consultancy, interim management) and managed services (outsourced IT/OT operations). No proprietary technology platform, API, AI/ML capability, or public pricing is disclosed, and the firm holds no recorded funding beyond an initial ~$118K round dated 2020-09-18; investor identities, cap-table structure, and customer logos are not publicly available.

MAASI Enterprises firmographics

Firmographics
Name
MAASI Enterprises
Legal name
MAASI Enterprises
Website
https://maasi.eu
Company type
Private
Founded year
2008
Operating status
Operating
Headcount range
11–50 employees
Short description
MAASI Enterprises is a London-based, privately held joint venture of European advisory firms providing technology and management advisory, IT/OT outsourcing, and interim management services to large multinational Pharmaceutical, Healthcare, and Biotechnology clients, with additional delivery capability from Italy.
Ownership category
akta.pro rank

MAASI Enterprises industry classification

Industry
Product category
Life Science Consulting
NAICS
Corporate, Subsidiary, and Regional Managing Offices (551114)
akta.pro industry
PRIMARYBPAHADAI
Strategic Partnerships, Alliances & JVs Advisory

Keywords

  • Life science consulting
  • Pharmaceutical advisory services
  • Biotechnology consultancy
  • Industrial cybersecurity consulting
  • IT/OT managed services

Where MAASI Enterprises is headquartered

Location

Headquarters

HQ city
London
HQ country
United Kingdom
HQ region
Europe

Markets served

MAASI Enterprises business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

  1. Advisory Services: Project-based advisory engagements covering M&A-related system and process migration, corporate standardisation, digital transformation, technology and process innovation, technology risk assessment and management, and industrial cybersecurity. Delivered by senior advisors to large multinational clients in Pharmaceutical, Healthcare and Biotechnology industries.
  2. Consultancy Services: 360° consulting engagements plus structured, SLA-defined outsourced technical IT and OT services and interim management placements. Engagements are tailor-made, structured and qualified to enterprise-grade standards.
  3. Operations Outsourcing (Managed Services): Tailor-made, structured, SLA-defined, enterprise-grade outsourced technical IT and OT services for life-science clients. Functions as a recurring managed-services revenue stream alongside project-based consulting.
  4. Interim Management: Medium- to long-term placement of qualified technical management professionals selected, trained and qualified by MAASI for client engagements.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractQuote-based advisory, consultancy, managed outsourcing and interim management engagements

Go-to-market motion1 record

MAASI Enterprises product offering

Product offering

Core offering

MAASI Enterprises delivers qualified advisory and consultancy services to large multinational enterprises in highly regulated life-science industries (Pharmaceutical, Healthcare, Biotechnology). Its portfolio covers M&A-related system and process migration, corporate standardisation, digital transformation, technology risk assessment and management, industrial cybersecurity, SLA-defined IT/OT operations outsourcing, and interim technical management.

Product overview

MAASI Enterprises delivers a unified advisory-and-consultancy service portfolio for the life-science industry rather than a discrete software product. The portfolio is organised around two core service lines — Advisory Services and Consultancy Services — each broken into named sub-offerings. Advisory Services comprises Advisory and Integration, M&A and Special Programmes, and Business Services and Technical Analysis; Consultancy Services comprises 360° Consulting, Operations Outsourcing, and Interim Management. Together, these two pillars allow MAASI Enterprises to combine strategic advisory (e.g., M&A migration, digital transformation, technology risk, industrial cybersecurity) with hands-on delivery (SLA-defined IT/OT outsourcing and interim technical management) for multinational Pharmaceutical, Healthcare, and Biotechnology clients.

Differentiator

Problem solved

Functional benefit

Products and services

  • Advisory Services

Companies that use MAASI Enterprises

Customer profile

Ideal customer profiles1 record

MAASI Enterprises technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

MAASI Enterprises partnerships and signals

Strategic signal

Recent moves6 records

Expansion highlights4 records

MAASI Enterprises competitors and assessment

Company assessment

Broad incumbents

  • Cognizant Life Sciences: Cognizant operates a global Life Sciences practice delivering IT services, digital transformation, regulatory compliance, and consulting to pharmaceutical and biotech clients — directly overlapping with MAASI's advisory and outsourcing offerings, but at vastly larger scale and with proprietary platforms.
  • Tata Consultancy Services (Life Sciences): TCS operates a dedicated Life Sciences & Healthcare practice delivering consulting, digital transformation, regulatory, and IT/OT services to global pharma and biotech clients — competing with MAASI for enterprise advisory and managed-services mandates.
  • Capgemini Engineering: Capgemini's life-sciences-focused engineering and IT services arm delivers digital transformation, M&A integration, and managed services to pharmaceutical clients, overlapping substantially with MAASI's advisory and IT/OT outsourcing offerings across European pharma accounts.
  • PwC Pharma & Life Sciences: PwC's Pharma & Life Sciences advisory practice covers strategy, M&A integration, technology risk, and digital transformation — directly comparable to MAASI's advisory portfolio for large multinational pharma, healthcare, and biotechnology clients.
  • Wipro Life Sciences: Wipro runs a dedicated Life Sciences business unit providing consulting, IT services, digital operations, and outsourcing to pharmaceutical and medical-device clients — competing with MAASI on enterprise-grade IT/OT services for life-science multinationals.
  • Accenture Life Sciences: Accenture's Life Sciences practice provides strategy, technology, consulting, and outsourcing to large multinational pharma, biotech, and medtech clients across M&A, digital transformation, cybersecurity, and operations — the same enterprise-grade service mix MAASI targets, but with global delivery scale MAASI cannot match.
  • Deloitte Life Sciences Consulting: Deloitte's Life Sciences practice delivers strategy, technology, risk advisory, and managed services to large pharma and biotech multinationals — competing directly with MAASI for advisory mandates around M&A, digital transformation, technology risk, and cybersecurity.
  • Infosys Life Sciences: Infosys's Life Sciences practice offers consulting, digital transformation, and managed services to global pharmaceutical and biotech firms, overlapping with MAASI's advisory, consultancy, and operations outsourcing pillars at much larger scale.

Direct peers

  • SL Controls: SL Controls is a specialist life-science-focused automation and OT systems integrator serving pharmaceutical and medical-device manufacturers in Europe — a closer boutique-level peer to MAASI's IT/OT operations outsourcing and industrial cybersecurity offerings for regulated clients.
  • NNIT (now part of NNIT A/S): NNIT is a Denmark-based IT services provider specialised in life sciences, offering infrastructure, application services, consulting, and managed services to pharmaceutical and biotech clients — a closer specialist peer to MAASI in scale, geography, and life-science-only focus.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

MAASI Enterprises social profiles

Digital presence

MAASI Enterprises compliance and trust

Trust signal

Compliance1 record

MAASI Enterprises financial estimates

Financial estimate

Revenue estimate

Valuation estimate

MAASI Enterprises leadership team

Management profile

Number of profiles

Profiles2 records

MAASI Enterprises funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

MAASI Enterprises M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MAASI Enterprises

What does MAASI Enterprises do?

MAASI Enterprises delivers qualified advisory and consultancy services to large multinational enterprises in highly regulated life-science industries (Pharmaceutical, Healthcare, Biotechnology). Its portfolio covers M&A-related system and process migration, corporate standardisation, digital transformation, technology risk assessment and management, industrial cybersecurity, SLA-defined IT/OT operations outsourcing, and interim technical management.

Is MAASI Enterprises a public or private company?

MAASI Enterprises is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was MAASI Enterprises founded?

MAASI Enterprises was founded in 2008. It employs 11 to 50 people.

Where is MAASI Enterprises based?

MAASI Enterprises is headquartered in London, United Kingdom, in the Europe region.

How does MAASI Enterprises make money?

Four revenue lines are on record. Advisory Services are the primary driver. The others are consultancy Services, operations Outsourcing (Managed Services) and interim Management.

Who are MAASI Enterprises's main competitors?

Broad incumbents on record are Cognizant Life Sciences, Tata Consultancy Services (Life Sciences), Capgemini Engineering, PwC Pharma & Life Sciences, Wipro Life Sciences, Accenture Life Sciences, Deloitte Life Sciences Consulting and Infosys Life Sciences. Direct peers are SL Controls and NNIT (now part of NNIT A/S).

Does MAASI Enterprises have an API?

No public API is recorded for MAASI Enterprises.

What industry is MAASI Enterprises in?

MAASI Enterprises's product category is Life Science Consulting. Its primary akta.pro industry code is BPAHADAI, Strategic Partnerships, Alliances & JVs Advisory. Its NAICS code is 551114.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales